Opendata, web and dolomites

ZikaPLAN SIGNED

Zika Preparedness Latin American Network

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ZikaPLAN" data sheet

The following table provides information about the project.

Coordinator
UMEA UNIVERSITET 

Organization address
address: UNIVERSITETOMRADET
city: UMEA
postcode: 901 87
website: www.umu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 12˙556˙056 €
 EC max contribution 11˙566˙373 € (92%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2016-RTD-Zika
 Funding Scheme /RIA
 Starting year 2016
 Duration (year-month-day) from 2016-10-01   to  2020-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UMEA UNIVERSITET SE (UMEA) coordinator 1˙611˙362.00
2    LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE UK (LONDON) participant 1˙958˙647.00
3    FUNDACAO UNIVERSIDADE DE PERNAMBUCO BR (RECIFE) participant 1˙244˙671.00
4    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 1˙030˙645.00
5    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 909˙446.00
6    FONDATION MERIEUX FR (LYON) participant 801˙250.00
7    ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL (ROTTERDAM) participant 649˙825.00
8    UNIVERSITY OF GLASGOW UK (GLASGOW) participant 625˙000.00
9    INSTITUTO BUTANTAN BR (SAO PAULO) participant 454˙687.00
10    UNIVERSITY OF ULSTER UK (COLERAINE) participant 304˙657.00
11    FUNDACION UNIVERSIDAD DEL NORTE CO (BARRANQUILLA) participant 274˙990.00
12    PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE BE (ANTWERPEN) participant 244˙500.00
13    ASSOCIACAO TECNICO CIENTIFICA ESTUDO COLABORATIVO LATINO AMERICANO DE MALFORMACAO CONGENITAS BR (RIO DE JANEIRO) participant 191˙150.00
14    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 183˙202.00
15    INSTITUTO DE MEDICINA TROPICAL PEDRO KOURI CU (LA HABANA) participant 173˙425.00
16    FUNDACAO OSWALDO CRUZ BR (RIO DE JANEIRO) participant 169˙347.00
17    QUEEN MARY UNIVERSITY OF LONDON UK (LONDON) participant 158˙401.00
18    UNIVERSIDAD DEL VALLE CO (CALI) participant 117˙711.00
19    THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL US (CHAPEL HILL) participant 106˙250.00
20    FUNDACAO DE APOIO A UNIVERSIDADE DE SAO PAULO BR (SAO PAULO) participant 100˙076.00
21    Institut Pasteur De Dakar SN (DAKAR) participant 99˙762.00
22    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 96˙750.00
23    LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY US (LA JOLLA CA) participant 60˙615.00
24    INTERNATIONAL VACCINE INSTITUTE KR (Seoul) participant 0.00
25    SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT CH (Basel) participant 0.00

Mappa

 Project objective

The ZikaPLAN initiative combines the strengths of 25 partners in Latin America, North America, Africa, Asia, and various centres in Europe to address the urgent research gaps (WP 1-8) in Zika, identifying short-and long term solutions (WP 9-10) and building a sustainable Latin-American EID Preparedness and Response capacity (WP 11-12). 
 We will conduct clinical studies to further refine the full spectrum and risk factors of congenital Zika syndrome (including neurodevelopmental milestones in the first 3 years of life), and delineate neurological complications associated with Zika due to direct neuroinvasion and immune-mediated responses. Laboratory based research to unravel neurotropism, investigate the role of sexual transmission, determinants of severe disease, and viral fitness will envelop the clinical studies.
 Burden of disease and modelling studies will assemble a wealth of data including a longitudinal cohort study of 17,000 subjects aged 2-59 in 14 different geographic locations in Brazil over 3 years. Data driven vector control and vaccine modelling as well as risk assessments on geographic spread of Zika will form the foundation for evidence-informed policies. The Platform for Diagnostics Innovation and Evaluation will develop novel ZIKV diagnostic tests in accordance with WHO Target Product Profiles. Our global network of laboratory and clinical sites with well-characterized specimens is set out to accelerate the evaluation of the performance of such tests. 
 Based on qualitative research, we will develop supportive, actionable messages to affected communities, and develop novel personal protective measures. Our final objective is for the Zika outbreak response effort to grow into a sustainable Latin-American network for emerging infectious diseases research preparedness. To this end we will engage in capacity building in laboratory and clinical research, collaborate with existing networks to share knowledge and tackle regulatory and other bottlenecks.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ZIKAPLAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ZIKAPLAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

EuroXpand (2018)

EUROpean clinical validation of a new ex vivo eXpanded stem cell theraPy for cArdiac regeNeration after acute myocarDial infarction: EUROXPAND

Read More  

NORMOPERF (2018)

Normothermic Perfusion Device for Renal and Hepatic Preservation and Viability Assessment

Read More  

DualDur (2018)

DualDur: A Disruptive Diagnostic Technology that Enables for the First Time an Early and Accurate Diagnosis of the tick-borne Lyme Disease.

Read More